Creative medical technology reports advancements in regenerative medicine and improvements in financial position in corporate update

Phoenix, az / accesswire / july 13, 2023 / creative medical technology holdings, inc. ("creative medical technology") (nasdaq:celz) recently released an update on their drug pipeline and financial standing going into q3 2023. the biotechnology company is known for its regenerative approach to immunotherapy, endocrinology, urology, gynecology and orthopedics.
CELZ Ratings Summary
CELZ Quant Ranking